FUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALS

Clinical trial NCT07674667 · RECRUITING

Trial details

NCT number: NCT07674667
Sponsor: Trace Neuroscience, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2026-08-01
Primary completion: 2027-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.